7Hay DM. Malignant Solid tumor of Childhood [J] . current problems in Surgery, 1986,23 : 198-210.
8Albert A, Cruz O, Montaner A, et al. Congenital solid tumors. A thirteewyear review [J]. Cir Pediatr,2004,17(3) : 133-136.
9Brace V,Grant SR, Brackley KJ, et al. Prenatal diagnosis and outcome in sacrocoecygeal teratomas:a review of cases between 1992 and 1998[J]. Prenat Diagn, 2000,20 ( 1 ) : 51-55.
10GomevMartinez R, SilvwPadilla N, Torres-Sauza B, et al. Solid malignant neoplasms in the first year of life[J]. An Pediatr(Barc), 2005,62(6): 529- 534.
3[1]Berthold F.Biology of neuroblastoma[A].Pochedly C.NeuroblastomaTumor Biology and Therapy[M].BostonCRC Press,1990.1～27.
4[2]Sawaguchi S,Kaneko M,Uchino J,et al.Treatment of advanced neuroblastoma with emphasis on intensive chemotherapya report from the Study Group of Japan[J].Cancer,1990,66:1879～1887.
5[3]Tsuchida Y,Ikeda H,Shitara T,et al.Evaluation of the results of neuroblastoma screening at six months of age[J].Med Pediatr Oncol,2000,34:80～81.
6[4]Committee of mass screening for neuroblastoma in Japanese Societyof pcdiatric Oncology.Annual reports the results of mass screening for neuroblastoma[C].Annual Meeting of Japanese Society of Pediatric Oncology,1998,197.
7[5]Sawada T.Past and future of neuroblastoma screening in Japan[J].Am J Pediatr Hematol/Oncol,1992,14:320～326.
8[6]Committee of Malignant Tumor of Society of the Japanese PediatricSurgeons.Registration of neuroblastoma,Wilms' tumor and hepatoblastoma during 6years from 1971 to 1976[J].J Jpn Soc Pediatr Surg,1997,15:507～515.
9[7]Sawada T,Matsumura T,Kawakatsu H,et al.Long-term effects of mass screening for neuroblastoma in infancy[J].Am J Pediatr Hematol Oncol,1991,133～7.
10[8]Nishi M.Mass screening for neuroblastoma using high-performance liquid chromatography and medical cost[J].Med Pediatr Oncol,1998,31:426～428.
